Acute Subdural Hematoma

Acute Subdural Hematoma Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07490197

Enrollment

100

Registered

2026-03-24

Start date

2024-01-30

Completion date

2028-02-01

Last updated

2026-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma

Brief summary

This retrospective data repository will serve as a means to aggregate and analyze standard surgical interventions and Middle Meningeal Arteryembolization as suitable treatment options for Acute Subdural Hematoma.

Detailed description

The primary objective of this study is to establish a data repository permissive of quality improvement studies/observations specific to patients with Acute Subdural Hematoma and evaluate impact of surgical interventions like burr hole trephination, Craniotomy, Decompressive Craniectomy, and Middle Meningeal Arteryembolization embolization on survival outcomes.

Interventions

OTHERMedical/Phenotype Data Collection Procedures & Data to be Collected

TheMethodist Dallas Medical Center Trauma Registry will be queried for demographic information, diagnosis codes, admission dates, traumatic injury characteristics, surgical procedures, comorbidities, inpatient outcomes, complications, consultations, discharge location, and mortality. Additional laboratory values will be abstracted from Epic through retrospective chart review.

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* ≥18 years old * Included in the Methodist Dallas Medical Center Trauma Registry * Acute subdural hematoma identified on computed tomography scan or magnetic resonance imaging of the brain in the trauma bay within 72 hours of a traumatic event

Exclusion criteria

* \<18 years old * Prisoners, pregnant persons, or other protected population

Design outcomes

Primary

Measure	Time frame	Description
Total Number of Study Sites	5 years	This study will include all trauma patients who meet registry inclusion and arrive at the Methodist Dallas Medical Center trauma bay with Acute subdural hematoma . Enrollment will terminate once adequate number of interventions have been observed for clinical significance to be established. We anticipate 5 years of data to be captured (January 2018 through December 2023).

Countries

United States

Contacts

CONTACTCrystee Cooper, DHEd

ClinicalResearch@mhd.com214-947-1280

CONTACTKavya Mankulangara

ClinicalResearch@mhd.com214-947-4604

PRINCIPAL_INVESTIGATORAndrew Karpisek, MD

Methodist Health System

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 5, 2026